PO-112 Role of microbiota in predicting oral mucositis in head and neck cancer patients treated with IMRT

Published on Mar 1, 2019in Radiotherapy and Oncology4.856
· DOI :10.1016/S0167-8140(19)30278-6
E. Orlandi3
Estimated H-index: 3
N.A. lacovelli1
Estimated H-index: 1
+ 14 AuthorsR. Valdagni4
Estimated H-index: 4
Cited By1
#1Hannah R. Wardill (University of Adelaide)H-Index: 16
#2Stephen T. Sonis (Brigham and Women's Hospital)H-Index: 81
Last. Joanne M. Bowen (University of Adelaide)H-Index: 49
view all 12 authors...
PURPOSE Despite advances in personalizing the efficacy of cancer therapy, our ability to identify patients at risk of severe treatment side effects and provide individualized supportive care is limited. This is particularly the case for mucositis (oral and gastrointestinal), with no comprehensive risk evaluation strategies to identify high-risk patients. We, the Multinational Association for Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) Mucositis Study Group, the...
1 CitationsSource